Max Robotics — Global Service Robot Directory + US Certification

About

Kristian Stensland is a urologic oncologist whose research focuses on improving outcomes and quality of life for men with prostate cancer. His work spans health equity, surgical outcomes, and postoperative care. In a landmark study, Stensland demonstrated that decisional regret after robotic-assisted laparoscopic prostatectomy is significantly higher in African American men, a finding with 36 citations that underscores critical disparities in surgical counseling and patient experience. He has also investigated the impact of metabolic syndrome on surgical outcomes and explored the role of statins in prostate cancer management, including their potential influence on active surveillance eligibility. Notably, Stensland led a quality improvement initiative that successfully reduced postoperative opioid pill prescribing, directly addressing the opioid epidemic by implementing evidence-based changes in surgical practice. His work on MRI-undetectable prostate tumors has further informed active surveillance protocols. With contributions that bridge clinical outcomes, health equity, and public health, Stensland’s research is shaping more personalized, equitable, and responsible care for men with prostate cancer.